KNO

Filter

2017
SIAXI: efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: results of phase III, placebo-controlled, randomized, double-blind study.
Blitzer, A., Friedman, A., Michel, O., Flatau-Baqué, B., Csikós, J. & Jost, W., jun 2017, SIAXI: efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: results of phase III, placebo-controlled, randomized, double-blind study. . I. P. A. M. D. S. (redactie). 1 redactie Wiley, Vol. 81. blz. 217-222 6 blz. (Cancer Chemotherapy and Pharmacology).
Onderzoeksoutput: Meeting abstract (Book)
50 Citaten (Scopus)

Onderzoeksoutput